Albemarle (ALB) is back in focus after its second quarter 2026 report showed US$1,743.31 million in sales and US$479.96 million in net income, alongside fresh full year guidance on revenue and lithium volumes.

Following Albemarle’s strong second quarter results and refreshed 2026 guidance, the stock’s recent 13.6% one-month share price return contrasts with a 20.97% decline over three months, while the one-year total shareholder return of 74.22% highlights how sentiment has shifted over a longer horizon.

If this earnings move has you rethinking exposure to critical materials and electrification, it can be useful to scan other potential opportunities in the supply chain such as 28 best rare earth metal stocks

Albemarle now combines a sharp rebound in profitability with a 1 year share price gain of 74.22%. The business appears strong based on recent numbers. The open question is whether the current price still offers value.

Most Popular Narrative: 28.3% Undervalued

Compared with Albemarle’s last close at $134.28, the most followed narrative applies a fair value of $187.16, using a 7.41% discount rate and a detailed earnings path.

Albemarle's disciplined capital spending (60% CapEx reduction YoY and ongoing prioritization of highest-return projects) and improved cash conversion is enabling it to generate positive free cash flow, strengthen its balance sheet, and provide greater financial flexibility for future growth, which can bolster earnings as demand recovers and pricing normalizes.

Want to understand why this fair value sits well above today’s share price? The narrative leans on a sharp swing in profitability, faster revenue expansion and a future earnings multiple that is lower than many peers. Curious how those pieces fit together into one pricing story? The full narrative lays out the numbers that link Albemarle’s current cash flows to that higher valuation.

Result: Fair Value of $187.16 (UNDERVALUED)

However, Albemarle’s story can change quickly if lithium oversupply keeps prices weak, or if regulatory and permitting setbacks disrupt planned capacity and project timelines.

Another View on Albemarle’s Valuation

The earlier narrative leans on earnings forecasts and a fair value of $187.16 for Albemarle. The market’s current P/S of 2.7x tells a different story. It is higher than the US Chemicals industry at 1.1x and above a fair ratio of 1.9x, which suggests investors are already paying up. How comfortable are you with that kind of valuation gap?

Next Steps

After weighing Albemarle’s latest results and valuation debates, do you feel the balance of risks and rewards justifies the current price, or not yet? To move quickly from headline impressions to your own judgment, take a closer look at the 3 key rewards and 1 important warning sign

Looking for more Albemarle style investment ideas?

If Albemarle has sharpened your focus, do not stop here. Use the Simply Wall St Screener to quickly spot other opportunities before they move out of reach.

• Target resilient income by reviewing companies in the 11 dividend fortresses that may suit a portfolio needing stronger cash returns.
• Hunt for potential value by scanning the screener containing 20 high quality undiscovered gems that the broader market might not be watching yet.
• Prioritise stability and capital preservation through the 77 resilient stocks with low risk scores if you want ideas with lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.